• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 25, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Researchers lengthen intervals between blood draws for warfarin patients

Bioengineer by Bioengineer
June 4, 2018
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new study finds stable patients on blood thinners may not need to get their blood drawn as often as they currently do. Researchers were able to increase the number of people waiting longer than five weeks in between their INR blood draws from less than half (41.8%) to more than two-thirds (69.3%).

"Warfarin patients with good INR control could have fewer blood draws, less discomfort and less cost," says Geoffrey Barnes, M.D., first author and cardiologist at the University of Michigan's Frankel Cardiovascular Center.

###

The U-M team published the new research in the Journal of Thrombosis and Haemostasis, thanks to participation in the Michigan Anticoagulation Quality Improvement Initiative (one of Blue Cross Blue Shield of Michigan's Collaborative Quality Initiatives). The paper studied 890 stable warfarin-treated patients in Michigan.

DOI: 10.1111/jth.14150

Media Contact

Haley Otman
[email protected]
734-764-2220
@umichmedicine

http://www.med.umich.edu

http://dx.doi.org/10.1111/jth.14150

Share12Tweet7Share2ShareShareShare1

Related Posts

Sense of Purpose Linked to Reduced Risk of Dementia, New Research Shows

August 25, 2025

Scientists Uncover Cellular Secret Weapon in the Fight Against Pathogens

August 25, 2025

Rising Polysubstance Use in Youth Opioid Overdoses Correlates with Age

August 25, 2025

How Gene-Diet Interactions Shape the Body’s Daily Rhythms

August 25, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    144 shares
    Share 58 Tweet 36
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Sense of Purpose Linked to Reduced Risk of Dementia, New Research Shows

Genetic Diversity in Nile Tilapia: A Conservation Review

Scientists Uncover Cellular Secret Weapon in the Fight Against Pathogens

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.